Landmark Bio is dedicated to translating cutting-edge research into life-changing therapies. Headquartered in Watertown, Massachusetts, the company was founded by leading academic institutions, research hospitals, and industry partners to accelerate the development, manufacturing, and commercialization of advanced therapies. Driven by the compelling science and transformative potential of genetic medicine, Landmark Bio offers deep drug development expertise and integrated end-to-end solutions to support its partners. The company also serves as a collaborative platform to advance next-generation manufacturing technologies for novel modalities. Following its acquisition by Artis BioSolutions in 2025, Landmark Bio continues to operate as a distinct entity.  Learn more at www.landmarkbio.com. 

 

We are seeking a highly motivated and team-oriented professional with entrepreneurial spirit to join our company! This is an exciting opportunity for a well-qualified candidate to join a rapidly growing company focused on turning today’s cutting-edge research into tomorrow’s breakthrough therapies.

We are seeking a high-performing Director, Business Development, Eastern U.S., to join our growing commercial team, focused on building and expanding strategic relationships in the Cell and Gene Therapy (CGT) space. The ideal candidate is a proven hunter who thrives on identifying and developing new business, understands the complex needs of biopharma clients, and can confidently represent technical capabilities across multiple advanced therapy modalities.

As part of a cutting-edge CDMO organization, you will be responsible for driving revenue growth and expanding our footprint with biotech and pharma partners across the U.S.

·       Prospect, identify, and close new business opportunities within the CGT ecosystem, including biotech, pharma, and emerging therapeutics companies

·       Generate new business by actively engaging with potential clients, qualifying them, and ultimately converting them into paying clients 

·       Develop and manage a territory plan focused on early stage to commercial partnerships

·       Effectively communicate technical capabilities in viral vector manufacturing, mRNA production, and cell & gene therapy platforms, with support from technical subject matter experts

·       Build strong, trust-based relationships with decision-makers across R&D, CMC, AP/PD, manufacturing and senior leadership teams

·       Drive the full sales cycle from lead generation through proposal development, negotiation, and close

·       Maintain accurate pipeline management and forecasting using CRM tools

·       Collaborate cross-functionally with marketing, technical teams, and program management to support client onboarding and long-term success

·       Consistently meet or exceed quarterly and annual forecast quotas

·       5+ years of successful B2B sales experience, with a minimum of 2 years selling into the CGT/CDMO space

·       Strong understanding of viral vectors, mRNA, and/or cell & gene therapy platforms — deeper technical knowledge in at least one modality required

·       Bachelor’s degree in a scientific discipline required; Master’s or PhD preferred

·       Prior hands-on lab experience is highly valued and will support credibility with scientific buyers

·       Proven track record of consistently meeting or exceeding quota

·       Demonstrated ability to build and grow new accounts with minimal oversight

·       Highly self-motivated, strategic thinker, and comfortable navigating technical, multi-stakeholder sales cycles

·       Excellent verbal and written communication skills, with the ability to tailor messages to both scientific and business audiences

- Ideally, candidate is located in the Northeast; other locations considered with strong qualifications

Landmark Bio is an Equal Opportunity, Affirmative Action employer. Minorities, women, veterans, and individuals with disabilities are encouraged to apply.